jsonp_parse_post_list([{"post_id":"v-69f70237-124f-3ea9-acd0-fc922af945e2_c-b14d07bb-d904-3e15-85c6-aa7cf39d57c3_a-a52b3f40-d32f-3e89-93bc-b8566253e8fa","post_url":"https:\/\/www.yahoo.com\/newsroom\/vibes\/world-news\/v-69f70237-124f-3ea9-acd0-fc922af945e2_c-b14d07bb-d904-3e15-85c6-aa7cf39d57c3_a-a52b3f40-d32f-3e89-93bc-b8566253e8fa","author":"nanook","provider":"Reuters Videos","lead_attribution":"provider","link":"https:\/\/www.yahoo.com\/news\/russia-evidence-syria-chemical-attack-131959257.html","imgresolutions":[{"url":"https:\/\/s.yimg.com\/uu\/api\/res\/1.2\/jviQGvf_0NdRd.TPlH7hCQ--\/YXBwaWQ9eXRhY2h5b247Zmk9c3RyaW07aD0zNjA7dz02NDA7\/http:\/\/media.zenfs.com\/en-US\/video\/video.reutersnews.com\/2018-04-13T131959Z_1_LOP000JXVRRCL_RTRMADP_BASEIMAGE-960X540_MIDEAST-CRISIS-SYRIA-RUSSIA-ROUGH-CUT.JPG","height":360,"width":640,"tag":"fit-width-640"},{"url":"https:\/\/s.yimg.com\/uu\/api\/res\/1.2\/NkhFPLa0UD0dMBQb5djwtw--\/YXBwaWQ9eXRhY2h5b247Zmk9c3RyaW07aD01NDA7dz05NjA7\/http:\/\/media.zenfs.com\/en-US\/video\/video.reutersnews.com\/2018-04-13T131959Z_1_LOP000JXVRRCL_RTRMADP_BASEIMAGE-960X540_MIDEAST-CRISIS-SYRIA-RUSSIA-ROUGH-CUT.JPG","height":540,"width":960,"tag":"original"}],"img":"http:\/\/media.zenfs.com\/en-US\/video\/video.reutersnews.com\/2018-04-13T131959Z_1_LOP000JXVRRCL_RTRMADP_BASEIMAGE-960X540_MIDEAST-CRISIS-SYRIA-RUSSIA-ROUGH-CUT.JPG","imgw":960,"imgh":540,"title":"Russia has evidence Syria chemical attack fabricated - Russian FM","summary":null,"published_at":1523643994,"content_id":"a52b3f40-d32f-3e89-93bc-b8566253e8fa","content_url":"https:\/\/www.yahoo.com\/news\/russia-evidence-syria-chemical-attack-131959257.html","content_published_at":1523625599,"content_time":1523625599,"content_relative_time":9,"reaction_count":0,"vibe_name":"World News","vibe_id":"69f70237-124f-3ea9-acd0-fc922af945e2","content_type":"video_link","aspect":1.78},{"post_id":"v-69f70237-124f-3ea9-acd0-fc922af945e2_c-76d7090f-b640-3ec4-adb9-8efc26fff238_a-dbeb9f23-4075-3ebe-b07f-4b25238bc3af","post_url":"https:\/\/www.yahoo.com\/newsroom\/vibes\/world-news\/strategic-rationale-behind-alexion%E2%80%99-acquisition-3t4pilv","author":"ipostwhaticareabout","provider":"Market Realist","lead_attribution":"provider","link":"http:\/\/marketrealist.com\/2018\/04\/strategic-rationale-behind-alexions-acquisition\/?utm_source=yahoo&utm_medium=feed&yptr=yahoo","imgresolutions":[{"url":"https:\/\/s1.yimg.com\/uu\/api\/res\/1.2\/FjGOkZ_HFo8FMpoVAA.MjA--\/YXBwaWQ9eXRhY2h5b247Zmk9c3RyaW07aD0zNjA7dz02NDA7\/http:\/\/media.zenfs.com\/en-US\/homerun\/marketrealist.com\/b083ca60234f7fc51093673ede0483c0","height":360,"width":640,"tag":"fit-width-640"},{"url":"https:\/\/s1.yimg.com\/uu\/api\/res\/1.2\/Z_RFyfEUitLP9JsxFYMzzA--\/YXBwaWQ9eXRhY2h5b247Zmk9c3RyaW07aD00NDA7dz02MTc7\/http:\/\/media.zenfs.com\/en-US\/homerun\/marketrealist.com\/b083ca60234f7fc51093673ede0483c0","height":440,"width":617,"tag":"original"}],"img":"http:\/\/media.zenfs.com\/en-US\/homerun\/marketrealist.com\/b083ca60234f7fc51093673ede0483c0","imgw":617,"imgh":440,"title":"Strategic Rationale behind Alexion\u2019s Acquisition","summary":"Wilson Therapeutics is a biopharmaceutical company focused on developing rare disease therapies. The company is listed on the Nasdaq Stockholm Exchange and has a market capitalization of 6.5 billion Swedish kronor. Wilson Therapeutics is developing a novel therapy to treat Wilson disease, which is a rare genetic and chronic disorder characterized by an accumulation of copper in the\u00a0brain, liver,\u00a0and other vital organs.","published_at":1523624910,"content_id":"dbeb9f23-4075-3ebe-b07f-4b25238bc3af","content_url":"http:\/\/marketrealist.com\/2018\/04\/strategic-rationale-behind-alexions-acquisition\/?utm_source=yahoo&utm_medium=feed&yptr=yahoo","content_published_at":1523624720,"content_time":1523624720,"content_relative_time":10,"reaction_count":0,"vibe_name":"World News","vibe_id":"69f70237-124f-3ea9-acd0-fc922af945e2","content_type":"link","aspect":null}]);